Blake Cameron, MD

Publications

Drake, Connor, Tyler Lian, Blake Cameron, Kate Medynskaya, Hayden B. Bosworth, and Kevin Shah. “Understanding Telemedicine's "New Normal": Variations in Telemedicine Use by Specialty Line and Patient Demographics.” Telemed J E Health, March 25, 2021. https://doi.org/10.1089/tmj.2021.0041.

PMID
33769092
Full Text

Foster, Gena G., Michael J. Grant, Samantha M. Thomas, Blake Cameron, Doug Raiff, Kelly Corbet, Gavin Loitsch, Christopher Ferreri, and Mitchell Horwitz. “Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function.” Biol Blood Marrow Transplant 26, no. 9 (September 2020): 1597–1606. https://doi.org/10.1016/j.bbmt.2020.05.007.

PMID
32450288
Full Text

Lunyera, Joseph, Dinushika Mohottige, Anastasia-Stefania Alexopoulos, Hilary Campbell, C Blake Cameron, Nicole Sagalla, Timothy J. Amrhein, et al. “Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.” Ann Intern Med 173, no. 2 (July 21, 2020): 110–19. https://doi.org/10.7326/M20-0299.

PMID
32568573
Full Text

Wosik, Jedrek, Marat Fudim, Blake Cameron, Ziad F. Gellad, Alex Cho, Donna Phinney, Simon Curtis, et al. “Telehealth transformation: COVID-19 and the rise of virtual care.” J Am Med Inform Assoc 27, no. 6 (June 1, 2020): 957–62. https://doi.org/10.1093/jamia/ocaa067.

PMID
32311034
Full Text

Schettini, Priscille, Kevin P. Shah, Colin P. O’Leary, Malhar P. Patel, John B. Anderson, Alex H. Cho, Andrea L. Long, Hayden B. Bosworth, and C Blake Cameron. “Keeping care connected: e-Consultation program improves access to nephrology care.” J Telemed Telecare 25, no. 3 (April 2019): 142–50. https://doi.org/10.1177/1357633X17748350.

PMID
29285981
Full Text

Foster, Yevgeniya, Michael J. Grant, Samantha M. Thomas, Blake Cameron, Doug Raiff, Kelly Corbet, Christopher Ferreri, and Mitchell E. Horwitz. “Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function.” In Blood, 132:4594–4594. American Society of Hematology, 2018. https://doi.org/10.1182/blood-2018-99-113189.

Full Text

Green, J. A., P. L. Ephraim, F. F. Hill-Briggs, T. Browne, T. S. Strigo, C. L. Hauer, R. A. Stametz, et al. “Putting patients at the center of kidney care transitions: PREPARE NOW, a cluster randomized controlled trial.” Contemp Clin Trials 73 (October 2018): 98–110. https://doi.org/10.1016/j.cct.2018.09.004.

PMID
30218818
Full Text

Cameron, Blake, Brian Douthit, and Rachel Richesson. “Data and knowledge standards for learning health: A population management example using chronic kidney disease.” Learn Health Syst 2, no. 4 (October 2018): e10064. https://doi.org/10.1002/lrh2.10064.

PMID
31245588
Full Text

Boggan, Joel C., Richard M. Atkins, David Simel, and Blake Cameron. “IDENTIFYING VETERANS AT HIGH-RISK FOR PROGRESSION TO END-STAGE RENAL DISEASE AND OPPORTUNITIES FOR NEPHROLOGY REFERRAL.” In Journal of General Internal Medicine, 32:S213–S213. SPRINGER, 2017.

Scholars@Duke

Crowley, Matthew J., Clarissa J. Diamantidis, Jennifer R. McDuffie, C Blake Cameron, John W. Stanifer, Clare K. Mock, Xianwei Wang, et al. “Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.” Ann Intern Med 166, no. 3 (February 7, 2017): 191–200. https://doi.org/10.7326/M16-1901.

PMID
28055049
Full Text

Pages